Travera operates a biotechnology platform that utilizes single-cell measurement technology to evaluate live cancer cells' responses to a panel of FDA-approved drugs, providing oncologists with actionable insights for personalized treatment plans. The Rapid Therapy Selection™ Test delivers results within two days, enabling precise drug selection based on the unique characteristics of each patient's cancer.
Funding
$21.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Oncologists often rely on empirical methods to select cancer treatments, leading to trial-and-error approaches that can delay effective therapy and expose patients to unnecessary side effects. Traditional methods lack the ability to rapidly assess a patient's live cancer cells' unique responses to various drug options.
Solution
Travera offers a biotechnology platform that employs single-cell measurement technology to evaluate the responses of live cancer cells to a panel of FDA-approved drugs. The Rapid Therapy Selection™ Test delivers results within two days, providing oncologists with actionable insights for personalized treatment plans. By testing live cancer cells against a panel of drugs, Travera identifies the drug options with the best potential to work for a patient's unique cancer, moving beyond the limitations of trial-and-error treatment selection.
Target Audience
The primary audience includes oncologists seeking personalized treatment plans for their patients and cancer patients looking for more informed treatment decisions.
Features
- Single-cell measurement technology to assess live cancer cell responses to drugs
- Rapid Therapy Selection™ Test delivers results within 48 hours of sample collection
- Testing against a panel of FDA-approved drugs, with a catalog of over 100 options
- Predictive accuracy validated in multiple clinical studies
- Customizable drug panels based on cancer type and stage, with up to 20 drugs tested per order